Hormone Therapy For Prostate Cancer May Increase Depression Risk

The New York Times (4/11, Bakalar) “Well” blog reports that research published in the Journal of Clinical Oncology suggests that “hormone therapy for prostate cancer may increase the risk for depression.” Investigators looked at data on more than 78,500 patients with prostate cancer, more than 33,300 of whom had undergone hormone therapy. The researchers found that “compared with those treated with other therapies,” patients “who received androgen deprivation therapy were 23 percent more likely to receive a diagnosis of depression, and they had a 29 percent increased risk of having inpatient psychiatric treatment.”

Related Links:

— “v,” Nicholas Bakalar, New York Times, April 11, 2016.

Posted in In The News.